Clinical trial

A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours

NCT04969835

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2021-07-16

PhasePHASE1

Study timeline

Study start (actual)2021-07-16Date precision: day

Registry last updated2026-10-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Salivary Gland Tumorunresolved

Urothelial Carcinomaunresolved

Ovarian Carcinomaunresolved

Breast Cancerunresolved

Soft Tissue Sarcomaunresolved

Interventions

AVA6000DRUG

Sponsors & collaborators

Avacta Life Sciences Ltdlead sponsor

Mapped research locations

New YorkNew York, United States1 HoustonTexas, United States1 LondonUnited Kingdom1 SeattleWashington, United States1 ManchesterUnited Kingdom1 GlasgowUnited Kingdom1 SheffieldUnited Kingdom1 LeedsUnited Kingdom1 Newcastle upon TyneUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04969835 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.